GLIMPSE GROUP INC/THE(NASDAQ:VRAR) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to VRAR. VRAR was compared to 82 industry peers in the IT Services industry. While VRAR seems to be doing ok healthwise, there are quite some concerns on its profitability. VRAR is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year VRAR has reported negative net income.

VRAR had a negative operating cash flow in the past year.

VRAR had negative earnings in each of the past 5 years.

In the past 5 years VRAR always reported negative operating cash flow.

1.2 Ratios

VRAR has a Return On Assets of -48.06%. This is amonst the worse of the industry: VRAR underperforms 89.87% of its industry peers.

VRAR has a Return On Equity of -66.93%. This is in the lower half of the industry: VRAR underperforms 77.22% of its industry peers.

		Industry Rank	Sector Rank
ROA	-48.06%
ROE	-66.93%
ROIC	N/A

ROA(3y)-58.09%

ROA(5y)-122.58%

ROE(3y)-110.23%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 72.04%, VRAR belongs to the best of the industry, outperforming 88.61% of the companies in the same industry.

In the last couple of years the Gross Margin of VRAR has grown nicely.

VRAR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	72.04%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y5.13%

GM growth 5Y3.11%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

VRAR does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, VRAR has more shares outstanding

The number of shares outstanding for VRAR has been increased compared to 5 years ago.

There is no outstanding debt for VRAR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

VRAR has an Altman-Z score of -1.13. This is a bad value and indicates that VRAR is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of -1.13, VRAR is not doing good in the industry: 91.14% of the companies in the same industry are doing better.

There is no outstanding debt for VRAR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-1.13

ROIC/WACCN/A

WACC11.68%

2.3 Liquidity

VRAR has a Current Ratio of 0.83. This is a bad value and indicates that VRAR is not financially healthy enough and could expect problems in meeting its short term obligations.

VRAR's Current ratio of 0.83 is on the low side compared to the rest of the industry. VRAR is outperformed by 86.08% of its industry peers.

A Quick Ratio of 0.83 indicates that VRAR may have some problems paying its short term obligations.

VRAR has a worse Quick ratio (0.83) than 86.08% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.83
Quick Ratio	0.83

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

VRAR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 75.12%, which is quite impressive.

VRAR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -35.59%.

The Revenue has been growing by 55.13% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)75.12%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%47.37%

Revenue 1Y (TTM)-35.59%

Revenue growth 3Y37.05%

Revenue growth 5Y55.13%

Sales Q2Q%-21.48%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y56.9%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year31.87%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VRAR. In the last year negative earnings were reported.

Also next year VRAR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

VRAR does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

GLIMPSE GROUP INC/THE

NASDAQ:VRAR (1/21/2025, 8:00:02 PM)

Premarket: 2.01 +0.08 (+4.15%)

1.93

-0.02 (-1.03%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustryIT Services

Earnings (Last)11-14 2024-11-14/amc

Earnings (Next)N/A N/A

Inst Owners19.06%

Inst Owner Change-0.01%

Ins Owners8.59%

Ins Owner Change1%

Market Cap39.10M

Analysts82.86

Price Target2.7 (39.9%)

Short Float %3.61%

Short Ratio0.14

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-2.12%

Min EPS beat(2)-22.55%

Max EPS beat(2)18.3%

EPS beat(4)3

Avg EPS beat(4)14.81%

Min EPS beat(4)-22.55%

Max EPS beat(4)32.13%

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-11.7%

Min Revenue beat(2)-15.33%

Max Revenue beat(2)-8.07%

Revenue beat(4)1

Avg Revenue beat(4)5.42%

Min Revenue beat(4)-15.33%

Max Revenue beat(4)56.59%

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)20%

EPS NY rev (1m)0%

EPS NY rev (3m)-400%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0%

Revenue NY rev (1m)-6.98%

Revenue NY rev (3m)-25.93%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	4.81
P/FCF	N/A
P/OCF	N/A
P/B	3.59
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-0.31

EYN/A

EPS(NY)-0.15

Fwd EYN/A

FCF(TTM)-0.2

FCFYN/A

OCF(TTM)-0.2

OCFYN/A

SpS0.4

BVpS0.54

TBVpS-0.02

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-48.06%
ROE	-66.93%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	72.04%
FCFM	N/A

ROA(3y)-58.09%

ROA(5y)-122.58%

ROE(3y)-110.23%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y5.13%

GM growth 5Y3.11%

F-Score5

Asset Turnover0.54

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	2.8%
Cap/Sales	0.42%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.83
Quick Ratio	0.83
Altman-Z	-1.13

F-Score5

WACC11.68%

ROIC/WACCN/A

Cap/Depr(3y)15.4%

Cap/Depr(5y)59.24%

Cap/Sales(3y)1.41%

Cap/Sales(5y)1.33%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)75.12%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%47.37%

EPS Next Y56.9%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-35.59%

Revenue growth 3Y37.05%

Revenue growth 5Y55.13%

Sales Q2Q%-21.48%

Revenue Next Year31.87%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y25.58%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y44.87%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y43.3%

OCF growth 3YN/A

OCF growth 5YN/A

GLIMPSE GROUP INC/THE (VRAR) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens